DKF Med Care
A Framework for the Legalization and Regulation of Cannabis in Canada
The Final Report of the Task Force on Cannabis Legalization and Regulation
Table of Contents
ForewordChapter 1: Introduction
• Our mandate
• The Canadian context
• A global perspective
• Setting the frame
• Public policy objectives
• Engagement process
• Guiding principles
• Introduction: a public health approach
• Minimum age
• Promotion, advertising and marketing restrictions
• Cannabis-based edibles and other products
• THC potency
• Tax and price
• Public education
• Prevention and treatment
• Workplace safety
• Introduction
• Production
• Distribution
• Retail
• Personal cultivation
• Introduction
• Illegal activities
• Personal possession
• Place of use
• Impaired driving
• Introduction
• One system or two?
• Access
• Affordability
• Products
• Public safety
• Evidence and research
• Capacity
• Oversight
• Co-ordination
• Communication
• Annex 2: Terms of Reference
• Annex 3: Acknowledgements
• Annex 4: Discussion Paper 'Toward the Legalization, Regulation and Restriction of Access to Marijuana'
• Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation
Medical cannabis (marijuana, marihuana) information
24 August 2016
Complete - Access to Cannabis for Medical Purposes Regulations (ACMPR)
Part 2 - Production for Own Medical Purposes and Production by a Designated Person
Tweed told CBC earlier this month they plan to provide rentable designated grow space services to the public.
TWEED FAQ - www.tweed.com/pages/frequently-asked-questions
Q. What is your Grow at Home Program going to look like?
A. We are exploring a number of options that range from selling base materials to renting space and everything inbetween. Nothing is finalized as of yet but we are working very diligently and look forward to announcing details.
August 11, 2016
As of August 24, 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) will replace the Marihuana for Medical Purposes Regulations (MMPR).
June 30, 2016
Government of Canada moves forward on Marijuana Legalization and Regulation
Participate up to August 29, 2016 by completing the online consultation questionnaire.
February 24, 2016
Federal Court Decision Allard v. Canada
Ban on medical cannabis patients growing their own cannabis struck down by Federal Court
Federal Court judge rules medical cannabis law unconstitutional
July 8, 2015
Health Canada Statement
news.gc.ca/web/article-en.do?mthd=tp&crtr.page=1&nid=997359&crtr.tp1D=980
Statement on Supreme Court of Canada Decision in R. v. Smith
THC limited to only 3%! CBD, CBN and other compounds no limits!
Sativex – a liquid extract of marijuana plants used in the treatment of certain symptoms associated with multiple sclerosis and certain kinds of pain; and
Cesamet – a capsule containing a synthetic version of THC, used in the management of nausea and vomiting associated with cancer chemotherapy.
Section 56 Exemptions:
Section 56 Class Exemption to Authorize the Conduct of Activities with Cannabis in Hospitals
March 31, 2014
Health Canada Medical Marihuana Purposes Regulations (MMPR) replaces
Health Canada Medical Marihuana Access Regulations (MMAR) program.
March 31, 2014
HEALTH CANADA MMAR LICENCE STATEMENT UPDATE:
http://www.hc-sc.gc.ca/dhp-mps/marihuana/access-access-eng.php
For immediate release
As a result of ongoing litigation and uncertainty arising from court decisions, Health Canada will treat the following Authorizations to Possess, Personal-Use Production Licences, and Designated-Person Production Licences as extending beyond March 31, 2014 until a decision in Allard is rendered. As per the Federal Court interim injunction, the following criteria must be met:
•Individuals must have held a valid Authorizations to Possess under the MMAR on March 21, 2014.
•Individuals must have held a valid Personal-Use Production Licence or Designated-Person Production Licence under the MMAR on, or after, September 30, 2013, where there is also an associated valid ATP as of March 21, 2014.
-30-
Media Inquiries:
Health Canada
(613) 957-2983
Public Inquiries:
(613) 957-2991
1-866 225-0709
Page 13 of 13